Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jordan E. Lake, MD, MSc
Houston AIDS Research Team CRS
Study Chair - Jorge A. Gallardo-Cartagena, MD
Barranco CRS
Study Chair - Kimberly K. Scarsi, PharmD, MS, FCCP
University of Nebraska
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nutrición-Mexico Crs (32078)
Mexico City, Tlalpan, Mexico
- Barranco Crs (11301)
Lima, Peru
- Thai Red Cross Aids Research Centre (trc-Arc) Crs (31802)
Bangkok, Patumwan, Thailand
- Chiang Mai University Hiv Treatment (cmu Hiv Treatment) Crs (31784)
Chiang Mai, Thailand
- Ucsd Antiviral Research Center Crs (701)
San Diego, California, United States
- University of California, San Francisco Hiv/aids Crs (801)
San Francisco, California, United States
- University of Colorado Hospital Crs (6101)
Aurora, Colorado, United States
- Whitman-Walker Institute, Inc. Crs (31791)
Washington D.C., District of Columbia, United States
- the Ponce de Leon Center Crs (5802)
Atlanta, Georgia, United States
- Johns Hopkins University Crs (201)
Baltimore, Maryland, United States
- Washington University Therapeutics (wt) Crs (2101)
St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center Crs (31786)
Newark, New Jersey, United States
- Weill Cornell Uptown Crs (site 7803)
New York, New York, United States
- Chapel Hill Crs (3201)
Chapel Hill, North Carolina, United States
- Greensboro Crs (3203)
Greensboro, North Carolina, United States
- Case Crs (2501)
Cleveland, Ohio, United States
- Vanderbilt Therapeutics Crs (3652)
Nashville, Tennessee, United States
- Houston Aids Research Team Crs (31473)
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jan 2024
- Primary completion
- 21 Aug 2025
- Completion
- 21 Aug 2025
- Last update posted
- 8 Apr 2026
- Registered enrollment
- 93
- Registry id
- NCT06005610
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.